Unknown

Dataset Information

0

Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis.


ABSTRACT: The aging liver is affected by several disorders, including steatosis, that can lead to a decline of liver functions. Here, we present evidence that the cdk4-C/EBPα-p300 axis is a critical regulator of age-associated disorders, including steatosis. We found that patients with non-alcoholic fatty liver disease (NAFLD) have increased levels of cdk4 and that cdk4-resistant C/EBPα-S193A mice do not develop hepatic steatosis with advancing age. Underlying mechanisms include a block in C/EBPα activation and subsequent failure in activation of enzymes involved in the development of NAFLD. Inhibition of cdk4 in aged wild-type (WT) mice by a specific cdk4 inhibitor, PD-0332991, reduces C/EBPα-p300 complexes and eliminates hepatic steatosis. Moreover, the inhibition of cdk4 in aged mice reverses many age-related disorders. Mechanisms of correction include elimination of cellular senescence and alterations in the chromatin structure of hepatocytes. Thus, the inhibition of cdk4 might be considered as a therapeutic approach to correct age-associated liver disorders.

SUBMITTER: Nguyen P 

PROVIDER: S-EPMC8209958 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5771394 | biostudies-literature
| S-EPMC7576254 | biostudies-literature
| S-EPMC6366969 | biostudies-literature
2018-04-01 | GSE104395 | GEO
| S-EPMC4908383 | biostudies-literature
| S-EPMC6240035 | biostudies-literature
| S-EPMC9817063 | biostudies-literature
| S-EPMC5215286 | biostudies-literature
| S-EPMC2773516 | biostudies-literature
| S-EPMC2993582 | biostudies-literature